PDF herunterladen
Endoscopy 2000; 32(10): 792-795
DOI: 10.1055/s-2000-7709
Short Communication
© Georg Thieme Verlag Stuttgart · New York

Massive Rectal Bleeding Following Transrectal Ultrasound-Guided Prostate Biopsy

E. Brullet 1 , M. C. Guevara 2 , R. Campo 1 , J. Falcóo 1 , J. Puig 1 , A. Prera 1 , J. Prats 1 , J. Del Rosario 2
  • 1 Corporació Sanitària Parc Taulí, Sabadell, Spain
  • 2 Hospital Universitario Insular, Las Palmas de Gran Canaria, Spain
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
31. Dezember 2000 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Background and Study Aims: Rectal bleeding is frequently seen in patients undergoing transrectal ultrasound (TRUS)-guided prostate biopsy, but is usually mild and stops spontaneously. We report five cases of life-threatening hemorrhage following this procedure, which were treated successfully by endoscopic injection.

Patients and Methods: A total of 550 consecutive patients underwent TRUS-guided prostate biopsy in an outpatient setting. TRUS was performed using a Sonolayer 140 A (Toshiba) unit with a 7-MHz biplane transrectal probe, which was covered with two prophylactic sheaths. Sextant prostatic biopsies were systematically performed with a 16-gauge or 18-gauge needle without antibiotic prophylaxis.

Results: Five patients (1 %) presented rectal bleeding with hypovolemic symptoms shortly after the procedure. Emergency colonoscopy revealed active bleeding from biopsy sites in the anterior rectal wall. Endoscopic injection of epinephrine and polidocanol achieved control of bleeding and permanent hemostasis in all cases. The patients required hospitalization and a mean of 4 packed red blood cell units (range 2 - 7). The patients were discharged, with uneventful recoveries.

Conclusions: Colonoscopy should be carried out in patients presenting severe rectal bleeding after TRUS-guided prostate biopsy. Endoscopic treatment can be used to deal with this rare complication.

References

  • 1 Rodriguez L V, Terris M K. Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature.  J Urol. 1998;  16 2115-2120
    PubMedGoogle Scholar
  • 2 Enlund A L, Varenhorst E. Morbidity of ultrasound-guided transrectal core biopsy of the prostate without prophylactic antibiotic therapy. A prospective study in 415 cases.  Br J Urol. 1997;  79 777-780
    PubMedGoogle Scholar
  • 3 Rietbergen J B, Kruger A E, Kranse R, Schröder F H. Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program.  Urology. 1997;  49 875-880
    CrossrefPubMedGoogle Scholar
  • 4 Herget E J, Saliken J C, Donnelly B J, et al. Transrectal ultrasound-guided biopsy of the prostate: relation between ASA use and bleeding complications.  Can Assoc Radiol J. 1999;  5 173-176
    PubMedGoogle Scholar
  • 5 Crundwell M CAU, Cooke P WAU, Wallace D MTI. Patients tolerance of transrectal ultrasound-guided prostatic biopsy: an audit of 104 cases.  BJU Int. 1999;  83 792-795
    CrossrefPubMedGoogle Scholar
  • 6 Clements R, Aideyan O U, Griffiths G J, Peeling W B. Side effects and patient acceptability of transrectal biopsy of the prostate.  Clin Radiol . 1993;  47 125-126
    PubMedGoogle Scholar
  • 7 Aus G, Hermansson C G, Hugosson  J, Pedersen K V. Transrectal ultrasound examination of the prostate: complications and acceptance by patients.  Br J Urol. 1993;  71 457-459
    PubMedGoogle Scholar
  • 8 Herranz Amo F, Rodriguez Fernandez E, et al. Morbilidad y tolerancia de la biopsia transrectal ecodirigida de la próstata.  Acta Urol Esp. 1996;  2 858-866
    PubMedGoogle Scholar
  • 9 Torp-Pedersen S, Lee F, Littrup P J, et al. Transrectal biopsy of the prostate guided with transrectal US: longuitudinal and multiplanar scanning.  Radiology. 1989;  17 23-27
    PubMedGoogle Scholar
  • 10 Collins G N, Lloyd S N, Hehir M, McKelvie G B. Multiple transrectal ultrasound guided biopsies: true morbidity and patient acceptance.  Br J Urol. 1993;  71 460-463
    PubMedGoogle Scholar
  • 11 Hammemer P, Huland H. Systematic sextant biopsies in 651 patients referred for prostate evaluation.  J Urol. 1994;  151 99-102
    PubMedGoogle Scholar
  • 12 Gustafsson O, Norming U, Nyman C R, Ohstrom M. Complications following combined transrectal aspiration and core biopsy of the prostate.  Scand J Urol Nephrol. 1990;  24 249-251
    PubMedGoogle Scholar
  • 13 Dauleh M I, Byrne D J. Severe bleeding following transrectal Tru-cut prostatic biopsy.  Scand J Urol Nephrol. 1996;  3 153-154
    PubMedGoogle Scholar
  • 14 Seymour M A, Oesterling J E. Anterior rectal wall hematoma: complication of transrectal ultrasound-guided biopsy of prostate.  Urology. 1992;  39 177-181
    CrossrefPubMedGoogle Scholar
  • 15 Hemal A K, Wadhwa S N, Taneja R. Trucut biopsy of the prostate: an unusual complication.  Br J Urol. 1994;  73 103-104
    PubMedGoogle Scholar
  • 16 Hogan J M, Johnson D E. Ureteral perforation: a complication of transrectal needle biopsy of the prostate.  J Urol. 1972;  108 297-298
    PubMedGoogle Scholar
  • 17 Steg A, Boccon-Gibod L, Olier C. Une complication exceptionelle de la ponction biopsie de la prostate: la perforation du grêle.  J Urol Nephrol. 1972;  78 929-931
    PubMedGoogle Scholar
  • 18 Norberg M. Transrectal ultrasound and core biopsies for the diagnoses of prostate cancer. A study of pretreatment investigation strategy for patients with suspected prostate cancer.  Acta Radiol. 1994;  393 Suppl 1-21
    PubMedGoogle Scholar

E. Brullet

Endoscopia Digestiva (UDIAT-CD)

Corporació Sanitària Parc Taulí 08208 Sabadell Spain

Fax: Fax:+ 34-3-7236187

eMail: E-mail:ebrullet@cspt.es